Adithya Balasubramanian ten23 health AG

With more than 15 years of experience in the biotech industry, including positions at Genentech, Regeneron, and Lonza, Adi is an experienced Business Development Director at ten23 health. Adi's expertise lies in external collaborations, alliance management, and pharmaceutical development, specifically in the areas of formulation development and in-use stability and compatibility. At ten23 health, Adi's primary focus is to identify new business opportunities for the company, build the ten23 brand, and provide strategic and tactical guidance to our Development teams. Adi began his career as a Research Associate at Regeneron and Genentech, where he worked on Eylea (Aflibercept), Praluent (Alirocumab), and Polivy (Polatuzumab vedotin). Adi played a pivotal role in establishing the technical operations team at ten23 health and Lonza Drug Product Services. Above all, Adi's true passion lies in creating innovative solutions that enhance patient outcomes and experiences.